LIEGE, Belgium and MARLBOROUGH, Mass.--(BUSINESS WIRE)--OncoMethylome Sciences (Euronext: ONCO) and EXACT Sciences Corporation (Nasdaq: EXAS) announced today that the companies have entered into agreements to advance the commercialization of stool-based colorectal cancer (CRC) screening technologies through service laboratories in Europe and North America.
